Investor · 1 deal
Every published round Tech23 took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Tessara Therapeutics Pty Ltd | Accelerator | undated | - | Participant | Forbes Australia, Startup Daily |
Companies Tech23 has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Tessara Therapeutics Pty Ltd | Accelerator | 1 | 0 |
Fund closes reported for Tech23, as distinct from the investments it has made.
Companies Tech23 has backed that another company then bought. An exit for the holding, not a deal Tech23 did.
Stories naming Tech23. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Startup Daily TV interviews Tessara Therapeutics' CEO about RealBrain, its 3D brain-tissue models for neurological drug discovery, and a fresh push to raise funds; the Melbourne biotech is also among the latest Tech23 companies.
Square Peg looks back on putting US$6 million into Airwallex's Series A+ alongside Tencent, Sequoia China, Gobi Partners and MasterCard, explaining why cross-border payment infrastructure needs fixing.